St. Louis-based Mercy recorded an operating income of $500.8 million (4.5% margin) for fiscal year 2026, up from $21.4 million (0.2% margin) in fiscal 2025, according to its Sept. 11 financial report.
Four things to know:
1. Mercy reported total operating revenue of $11.1 billion for the 12 months ended June 30, a 9.4% increase year over year. Patient service revenue rose 8.4% year over year to $9.9 billion. Other operating revenues increased 70.6% to $671.7 million, while capitation revenues declined 15.2% to $522.1 million.
2. Total operating expenses were $10.6 billion for fiscal 2026, a 4.7% increase year over year. Salaries and benefits totaled $5.7 billion, a 1.1% increase year over year. Supplies and other expenses totaled $4.2 billion, a 12.8% increase, while medical claims expenses declined 25.1% to $248.5 million.
3. Medicare made up the largest share of patient service revenue growth, rising to $4.4 billion in fiscal 2026 from $3.8 billion a year earlier, a 16.2% increase. Medicaid revenue grew 13.3% to $1.1 billion. Managed care and other commercial revenue was roughly flat at $4.3 billion, while self-pay revenue declined 20.6% to $107.4 million. Government payers — Medicare and Medicaid combined — accounted for about 44% of net accounts receivable at year-end, up slightly from 43% the prior year, with one managed care payer representing 18% of net accounts receivable in both years.
4. Mercy reported a net income of $1.1 billion in fiscal 2026, up from $302.5 million during the same period last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
